Try our Advanced Search for more refined results

ITC Refuses To OK Amgen, Roche Anemia Drug Deal

By Jacqueline Bell (November 10, 2011, 6:40 PM EST) -- The U.S. International Trade Commission on Wednesday finally dropped its investigation into a patent fight between Amgen Inc. and Roche Holding Ltd. over an anemia drug after their 2009 settlement, but refused to approve what it said was an unusual consent order requested by the parties....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Attached Documents

Related Sections

Law Firms

Companies

Government Agencies

Patents

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!